Literature DB >> 28766178

Differential Regulation of IL-1β and IL-6 Release in Murine Macrophages.

Seishiro Hirano1, Quan Zhou2,3, Akiko Furuyama2, Sanae Kanno4.   

Abstract

Asbestos and silica (exogenous danger) and adenosine triphosphate (ATP, endogenous danger-signaling molecule) synergistically increase IL-1β release from endotoxin-primed macrophage, which is mediated by NOD-like receptor protein 3 (NLRP3) inflammasome. However, the conversion of pro-IL-1β to its active form seems to depend on the macrophage cell types. In the present study, bone marrow-derived macrophages (BMM) and three murine macrophage cell lines, J774.1, J774A.1, and RAW264.7 were exposed to ATP or fibrous titanium dioxide (FTiO2) in the presence or absence of lipopolysaccharide (LPS), and the concentrations of IL-1β and IL-6 in both cell lysates and in the culture media were measured by immunoblotting to differentiate active form of IL-1β from pro-IL-1β. IL-1β release was synergistically increased when the cells were exposed to both LPS and ATP or FTiO2, while IL-6 was readily released by LPS alone. IL-1β released into the culture medium was pro-IL-1β in J774.1 and RAW264.7, and most of the pro-IL-1β remained inside the cells. In contrast, the active form of IL-1β was released together with pro-IL-1β from J774A.1 and BMM after the co-stimulation. J774A.1 and BMM express apoptosis-associated speck-like protein contains a carboxyl-terminal CARD (ASC) while J774.1 and RAW264.7 do not or only faintly express ASC, and accordingly, caspase-1, which converts pro-IL-1β to its active form, is activated only in J774A.1 and BMM. Collectively, the canonical inflammasome pathway is not activated in J774.1 and RAW264.7, and the apparent synergistical increase of IL-1β in the culture medium mostly reflects the leakage of pro-IL-1β from these cells.

Entities:  

Keywords:  IL-1β; IL-6; caspase-1; inflammasome; macrophages

Mesh:

Substances:

Year:  2017        PMID: 28766178     DOI: 10.1007/s10753-017-0634-1

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  15 in total

1.  Cell type-specific mechanisms coupling protease-activated receptor-1 to infectious colitis pathogenesis.

Authors:  Alexander A Boucher; Leah Rosenfeldt; Duaa Mureb; Jessica Shafer; Bal Krishan Sharma; Adam Lane; Rebecca R Crowther; Melanie C McKell; Jordan Whitt; Theresa Alenghat; Joseph Qualls; Silvio Antoniak; Nigel Mackman; Matthew J Flick; Kris A Steinbrecher; Joseph S Palumbo
Journal:  J Thromb Haemost       Date:  2019-10-11       Impact factor: 5.824

2.  LncRNA MIAT downregulates IL-1β, TNF-ɑ to suppress macrophage inflammation but is suppressed by ATP-induced NLRP3 inflammasome activation.

Authors:  Ziye Wang; Yang Kun; Zhao Lei; Wen Dawei; Pan Lin; Wang Jibo
Journal:  Cell Cycle       Date:  2021-01-18       Impact factor: 4.534

3.  Rosiglitazone alleviates lipopolysaccharide-induced inflammation in RAW264.7 cells via inhibition of NF-κB and in a PPARγ-dependent manner.

Authors:  Jing-Ping Zhou; Xiao-Ning Yang; Yang Song; Fei Zhou; Jing-Jing Liu; Yi-Qun Hu; Li-Gang Chen
Journal:  Exp Ther Med       Date:  2021-05-11       Impact factor: 2.447

4.  Kv1.5 channel mediates monosodium urate-induced activation of NLRP3 inflammasome in macrophages and arrhythmogenic effects of urate on cardiomyocytes.

Authors:  Peili Li; Yasutaka Kurata; Fikri Taufiq; Masanari Kuwabara; Haruaki Ninomiya; Katsumi Higaki; Motokazu Tsuneto; Yasuaki Shirayoshi; Miguel A Lanaspa; Ichiro Hisatome
Journal:  Mol Biol Rep       Date:  2022-04-04       Impact factor: 2.742

5.  Extracellular glucose is crucially involved in the fate decision of LPS-stimulated RAW264.7 murine macrophage cells.

Authors:  Toshihiko Aki; Takeshi Funakoshi; Kanako Noritake; Kana Unuma; Koichi Uemura
Journal:  Sci Rep       Date:  2020-06-29       Impact factor: 4.379

Review 6.  Cellular Models and Assays to Study NLRP3 Inflammasome Biology.

Authors:  Giovanni Zito; Marco Buscetta; Maura Cimino; Paola Dino; Fabio Bucchieri; Chiara Cipollina
Journal:  Int J Mol Sci       Date:  2020-06-16       Impact factor: 5.923

7.  Jiaweishaoyao Decoction Alleviates DSS-Induced Ulcerative Colitis via Inhibiting Inflammation.

Authors:  Huixia Qiao; Yahui Huang; Xiaoyan Chen; Long Yang; Yue Wang; Rongrong Xu
Journal:  Gastroenterol Res Pract       Date:  2020-05-27       Impact factor: 2.260

Review 8.  Focused evaluation of the roles of macrophages in chimeric antigen receptor (CAR) T cell therapy associated cytokine release syndrome.

Authors:  Hanfei Guo; Lei Qian; Jiuwei Cui
Journal:  Cancer Biol Med       Date:  2021-09-28       Impact factor: 4.248

9.  L-plastin enhances NLRP3 inflammasome assembly and bleomycin-induced lung fibrosis.

Authors:  Hemant Joshi; Alison Almgren-Bell; Edgar P Anaya; Elizabeth M Todd; Steven J Van Dyken; Anushree Seth; Katherine M McIntire; Srikanth Singamaneni; Fayyaz Sutterwala; Sharon C Morley
Journal:  Cell Rep       Date:  2022-03-15       Impact factor: 9.423

10.  Never Change a Flowing System? The Effects of Retrograde Flow on Isolated Perfused Lungs and Vessels.

Authors:  Hanif Krabbe; Sergej Klassen; Johannes Bleidorn; Michael J Jacobs; Julia Krabbe; Aaron Babendreyer; Christian Martin
Journal:  Cells       Date:  2021-05-15       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.